  We present a theoretical agent-based model of cell evolution under the action
of cytotoxic treatments, such as radioteraphy or chemoteraphy. The major
features of cell cycle and proliferation, cell damage and repair, and chemical
diffusion are included. Cell evolution is based on a discrete Markov chain,
with cells stepping along a sequence of discrete internal states from 'normal'
to 'inactive'. Probabilistic laws are introduced for each type of event a cell
can undergo during its life cycle: duplication, arrest, apoptosis, senescence,
damage, healing. We adjust the model parameters on a series of cell irradiation
experiments, carried out in a clinical LINAC at 20 MV, in which the damage and
repair kinetics of single- and double-strand breaks are followed. Two showcase
applications of the model are then presented. In the first one, we reconstruct
the cell survival curves from a number of published low- and high-dose
irradiation experiments. We reobtain a very good description of the data
without assuming the well-known linear-quadratic model, but instead including a
variable DSB repair probability, which is found to spontaneously saturate with
an exponential decay at increasingly high doses. As a second test, we attempt
to simulate the two extreme possibilities of the so-called 'bystander' effect
in radiotherapy: the 'local' effect versus a 'global' effect, respectively
activated by the short-range or long-range diffusion of some factor, presumably
secreted by the irradiated cells. Even with an oversimplified simulation, we
could demonstrate a sizeable difference in the proliferation rate of
non-irradiated cells, the proliferation acceleration being much larger for the
global than the local effect, for relatively small fractions of irradiated
cells in the colony.
